Table 3

 CSF levels and ratio of NfH phosphoforms for clinically progressive versus stable patients at baseline. Values are median (interquartile range)

MS (all patients)SP/PPRR
StableProgressiveStableProgressiveStableProgressive
See table 2 for abbreviations.
Number191516738
NfHSMI35 (pg/ml)38 (17–155)107 (49–163)42 (24–173)104 (78–173)5 (0–53)115 (43–165)
NfHSMI34 (pg/ml)11 (5–13)8 (5–14)11 (7.5–13.0)9 (5–16)2 (0–5)7.5 (6–11)
Ratio3.2 (0.6–5.8)1.0 (0.4–3.5)3.2 (0.6–6.0)1.1 (0.5–1.7)2.5 (0.9–4.0)0.9 (0.4–3.5)